Disseminating your research findings to a range of stakeholders is an important part of the research impact process. The key is to think about ‘who’ might possibly benefit from knowing more about your research, and importantly, ‘how’ could they use your findings to support, inform and develop their practice.
A good example of this process is the recent keynote address delivered by Prof. John Oliver (FMC) to more than 60 delegates at a one-day event that launched the new Centre of Excellence, Enterprise Portfolio Management Office (UK Parliament). Prof. Oliver’s talk entitled ‘Harnessing the Power of Scenario Planning’ presented the findings of his scenario-planning project that ultimately developed a mission, vision and strategy for the House of Commons Library Service in UK Parliament. Additional keynotes were given by the Chief Operating Officer (House of Lords) and a range of internal and external experts on project delivery and digital transformation.
Prof. Oliver’s work is published in Oliver, J.J., Reid, M., and Gray, K. (2023). The Library of the Future: a scenario-based approach. Journal of Library Administration, Volume 63, Issue 1, Pages
27-41
Prof.John Oliver appointed to UK Parliament Centre of Excellence
Developing Instrumental Impact: UK House of Commons
UN Development Programme (UNDP): Strategic Foresight
Dr John Oliver awarded Parliamentary Fellowship










Join the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease